Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership380,561 shares
Latest Disclosed Value $ 5,331,666
Fmr Llc reports 4.11% increase in ownership of AVNS / Avanos Medical, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 380,561 shares of Avanos Medical, Inc. (US:AVNS) valued at $5,331,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 365,545 shares of Avanos Medical, Inc.. This represents a change in shares of 4.11% during the quarter. The current value of the position is $9,514,025 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVANOS MED COM 05350V106 380,561 15,016 4.11 5,332 29.87 0.0001
2026-02-17 2025-12-31 13F AVANOS MED COM 05350V106 365,545 94,528 34.88 4,105 31.07 0.0002
2025-11-13 2025-09-30 13F AVANOS MED COM 05350V106 271,017 66,472 32.50 3,133 25.13 0.0002
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 204,545 44 0.02 2,504 -14.57 0.0001
2025-05-12 2025-03-31 13F AVANOS MED COM 05350V106 204,501 58,367 39.94 2,931 25.97 0.0002
2025-02-13 2024-12-31 13F AVANOS MED COM 05350V106 146,134 12,290 9.18 2,326 -27.67 0.0001
2024-11-13 2024-09-30 13F AVANOS MED COM 05350V106 133,844 34,421 34.62 3,216 62.42 0.0002
2024-08-13 2024-06-30 13F AVANOS MED COM 05350V106 99,423 -44,694 -31.01 1,981 -30.99 0.0001
2024-05-13 2024-03-31 13F AVANOS MED COM 05350V106 144,117 -6,868 -4.55 2,869 -15.27 0.0002
2024-02-13 2023-12-31 13F AVANOS MED COM 05350V106 150,985 -13,856 -8.41 3,387 1.59 0.0003
2023-11-13 2023-09-30 13F AVANOS MED COM 05350V106 164,841 8,966 5.75 3,333 -16.34 0.0003
2023-08-11 2023-06-30 13F AVANOS MED COM 05350V106 155,875 22,585 16.94 3,984 0.50 0.0003
2023-08-11 2023-03-31 13F/A-1 AVANOS MED COM 05350V106 133,290 14,871 12.56 3,964 23.72 0.0004
2023-05-11 2023-03-31 13F AVANOS MED COM 05350V106 133,290 14,871 3,964 0.0001
2023-02-13 2022-12-31 13F AVANOS MED COM 05350V106 118,419 11,584 10.84 3,204 37.69 0.0003
2022-11-10 2022-09-30 13F AVANOS MED COM 05350V106 106,835 651 0.61 2,327 -19.84 0.0002
2022-08-12 2022-06-30 13F AVANOS MED COM 05350V106 106,184 84,250 384.11 2,903 294.97 0.0003
2022-05-13 2022-03-31 13F AVANOS MED COM 05350V106 21,934 20,664 1,627.09 735 1,570.45 0.0001
2022-02-14 2021-12-31 13F AVANOS MED COM 05350V106 1,270 503 65.58 44 83.33 0.0000
2022-02-14 2021-09-30 13F/A-1 AVANOS MED COM 05350V106 767 117 18.00 24 0.00 0.0000
2021-11-15 2021-09-30 13F AVANOS MED COM 05350V106 767 117 24 0.0000
2021-08-13 2021-06-30 13F AVANOS MED COM 05350V106 650 24 3.83 24 -11.11 0.0000
2021-05-14 2021-03-31 13F AVANOS MED COM 05350V106 626 -204 -24.58 27 -28.95 0.0000
2021-02-08 2020-12-31 13F AVANOS MED COM 05350V106 830 265 46.90 38 100.00 0.0000
2020-11-13 2020-09-30 13F AVANOS MED COM 05350V106 565 -105 -15.67 19 -5.00 0.0000
2020-08-24 2020-06-30 13F/A-1 AVANOS MED COM 05350V106 670 -552 -45.17 20 -39.39 0.0000
2020-08-13 2020-06-30 13F AVANOS MED COM 05350V106 670 -552 20 0.4913
2020-05-14 2020-03-31 13F AVANOS MED COM 05350V106 1,222 -1,239 -50.35 33 -60.24 0.0000
2020-02-07 2019-12-31 13F AVANOS MED COM 05350V106 2,461 -208,692 -98.83 83 -98.95 0.0000
2019-11-13 2019-09-30 13F AVANOS MED COM 05350V106 211,153 -35 -0.02 7,910 -14.12 0.0009
2019-08-13 2019-06-30 13F AVANOS MED COM 05350V106 211,188 -63,030 -22.99 9,210 -21.30 0.0011
2019-05-13 2019-03-31 13F AVANOS MED COM 05350V106 274,218 -30,078 -9.88 11,703 -14.14 0.0014
2019-02-13 2018-12-31 13F AVANOS MED COM 05350V106 304,296 62,112 25.65 13,630 -17.84 0.0019
2018-11-09 2018-09-30 13F AVANOS MED COM 05350V106 242,184 242,184 16,590 0.0019
2017-02-10 2016-12-31 13F HALYARD HEALTH COM 40650V100 0 0 0 0.0000
2016-11-14 2016-09-30 13F HALYARD HEALTH COM 40650V100 0 -86,682 -100.00 0 -100.00
2016-08-11 2016-06-30 13F HALYARD HEALTH COM 40650V100 86,682 3,788 4.57 2,819 18.35 0.0004
2016-05-16 2016-03-31 13F HALYARD HEALTH COM 40650V100 82,894 200 0.24 2,382 -13.79 0.0003
2016-02-12 2015-12-31 13F HALYARD HEALTH COM 40650V100 82,694 -67,460 -44.93 2,763 -35.29 0.0004
2015-11-10 2015-09-30 13F HALYARD HEALTH COM 40650V100 150,154 7,358 5.15 4,270 -26.16 0.0006
2015-08-25 2015-06-30 13F/A-1 HALYARD HEALTH COM 40650V100 142,796 15,642 12.30 5,783 -7.56 0.0007
2015-08-13 2015-06-30 13F HALYARD HEALTH COM 40650V100 142,796 5,783
2015-05-14 2015-03-31 13F HALYARD HEALTH COM 40650V100 127,154 11,090 9.56 6,256 18.55 0.0008
2015-02-17 2014-12-31 13F HALYARD HEALTH COM 40650V100 116,064 116,064 5,277 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.